GlaxoSmithKline Earnings, Revenue beat In Q2

  • Investing.com
GlaxoSmithKline Earnings, Revenue beat In Q2

Investing.com - GlaxoSmithKline (LON: GSK ) reported on Wednesday second quarter earnings that beat analysts' forecasts and revenue that topped expectations.

GlaxoSmithKline announced earnings per share of £0.281 on revenue of £8.09B. Analysts polled by Investing.com anticipated EPS of £0.1982 on revenue of £7.6B.

GlaxoSmithKline shares are up 12% from the beginning of the year and are trading at £1,401.80 , down-from-52-week-high.They are under-performing the OMX Helsinki 25 which is up 22.26% from the start of the year.

GlaxoSmithKline shares gained 0.19% in intra-day trade the report.

GlaxoSmithKline follows other major Healthcare sector earnings this month

GlaxoSmithKline's report follows an earnings beat by ReNeuron on Thursday, July 8, 2021, who reported EPS of £-0.09 on revenue of £216.0K, compared to forecasts EPS of £-12.70 on revenue of £1.00M.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100